Key facts
- The deputy secretary of defense determined WuXi AppTec should be removed in compliance with an August 7 court order.
- The Pentagon said it could designate WuXi AppTec again if additional grounds emerge.
- WuXi AppTec said the injunction does not constitute a final resolution of the legal dispute.
- WuXi AppTec's Shanghai-listed shares advanced roughly 1% on November 10, 2026.
WuXi AppTec shares rose on November 10, 2026, after the US Department of Defense removed the Chinese biotech services company from its list of "Chinese military companies," according to a Federal Register notice published that day. The notice was signed on November 5 by the deputy secretary of defense, who determined the company should be removed in compliance with an August 7 order from the US District Court for the District of Columbia.
The court had granted WuXi AppTec's request for a preliminary injunction, preventing the Pentagon from enforcing the designation under Section 1260H of the National Defense Authorization Act for Fiscal Year 2021. The company had been added to the list on June 8, 2026, when the Pentagon expanded the roster to 188 entities, and filed its complaint on June 11.
WuXi AppTec's Hong Kong-listed shares rose 1.7% to HK$201.40, while the Hang Seng Index was up about 0.7% in early trading, according to Tulsian AI. Shanghai-listed shares advanced roughly 1%. The Pentagon said the company could be placed back on the list if additional or supplementary grounds emerge, and WuXi AppTec said the preliminary injunction does not constitute a final resolution of the underlying legal dispute.